Skip to main content
OpenTrials

Clinical trial condition

Leukemia, B-Cell

Explore clinical trials studying Leukemia, B-Cell. Study availability and eligibility vary by location and protocol.

1,386 public trials 160 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, B-Cell trial results

Recruiting

Testing the Effectiveness of the Anti-cancer Drug, Mirdametinib, in Treating Relapsed, Refractory Chronic Lymphocytic Leukemia

NCT07061951

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +17 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • City of Hope at Irvine Lennar Irvine, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Recruiting

A Study of Emavusertib + An Approved Bruton Tyrosine Kinase Inhibitor (BTKi) in Participants With Chronic Lymphocytic Leukemia (CLL) and Other B-cell Malignancies

NCT07271667

Conditions
B-cell Malignancies, Chronic Disease, Chronic Lymphocytic Leukemia, +15 more
Locations
  • Mt Sinai Comprehensive Cancer Center Miami Beach, Florida, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Summit Medical Group Florham Park, New Jersey, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
View Trial Details
Recruiting

Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell Malignancies

NCT06980116

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +38 more
Locations
  • LLC ARENSIA Exploratory Medicine Tbilisi, Georgia
  • IMSP Institute of Oncology, ARENSIA Exploratory Medicine Chisinau, Moldova
  • Hospital Beata Maria Ana Madrid, Spain
  • Hospital Fundación Jiménez Diaz Madrid, Spain
View Trial Details
Recruiting

Faecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation

NCT04935684

Conditions
Acute Leukemia in Remission, Bone Marrow Diseases, Chronic Disease, +27 more
Locations
  • Service d'Hématologie Clinique et Thérapie Cellulaire CHU Amiens Picardie - Site Sud Amiens, France
  • Service Maladies du sang CHU Angers Angers, France
  • Hématologie clinique CHU Besançon Besançon, France
  • Plateforme d'Investigation Clinique / Centre d'Investigation Clinique - Inserm 1405, CHU Gabriel Montpied Clermont-Ferrand Clermont-Ferrand, France
View all 20 locations
View Trial Details
Recruiting

A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.

NCT06697184

Conditions
CLL, Chronic Disease, Chronic Lymphocytic Leukemia, +22 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Fort Wayne Medical Oncology and Hematology Fort Wayne, Indiana, United States
  • The University of Kansas Cancer Center Westwood, Kansas, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View all 17 locations
View Trial Details
Recruiting

A Study of DZD8586 Versus Investigator's Choice in r/r CLL/SLL (TAI-SHAN6)

NCT07139873

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Disease Attributes, +14 more
Locations
  • First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital Nanjing, Jiangsu, China
  • National Clinical Research Center for Blood Diseases, Blood Disease Hospital & Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College Tianjin, Tianjin Municipality, China
View Trial Details

Related conditions